P Juret

Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancers

P Juret, A Tanguy, A. Girard et al. · European Journal of Cancer (1965) · 1978 · 85 citations

Oncology, Chemoprevention Strategy, Preliminary Trial +8

SEX OF FIRST CHILD AS A PROGNOSTIC FACTOR IN BREAST CANCER

P Juret, T. Delozier, A.M. Mandard et al. · The Lancet · 1978 · 48 citations

First Child, Breast Oncology, Medicine +7

Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial

T. Delozier, Jean‐Pierre Julien, P Juret et al. · Breast Cancer Research and Treatment · 1986 · 45 citations

Postmenopausal Breast Cancer, Breast Oncology, Medicine +9

Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experience.

P Juret, Héron Jf, Couette Je et al. · PubMed · 1982 · 38 citations

Bone Disease, Tumor Biology, Urology +12

Age at menarche as a prognostic factor in human breast cancer

P Juret, J.E. Couette, A.M. Mandard et al. · European Journal of Cancer (1965) · 1976 · 25 citations

Breast Oncology, Longevity, Prognostic Factor +11